Salvo Health offers brick-and-mortar gastrointestinal (GI) clinics a continuous virtual care platform that connects patients with a specialized, gut-focused care team. Users gain direct, ongoing access to registered dietitians, behavioral-health professionals, and nurses, helping clinics save time, boost revenue, and improve outcomes. In 2025 the company reported 800% year-over-year growth in both patients and revenue and expanded enterprise agreements with GI doctors by more than 1,000%, reaching 801 signed GI partners. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, the company is now building an AI-driven product roadmap. The new funding will finance engineering expansion and nationwide hiring of additional clinical staff to meet rising demand. Salvo Health positions itself at the intersection of virtual specialty care and chronic condition management, with ambitions to scale its platform nationally.

Total raised

$24M

Funding rounds

3

Latest round

Series A

Latest activity

Jan 2026